SITC 2017 Microlearning: Toxicities Series

SITC_Friday_2017_Khaaliq_Thomas-21.jpgThe SITC 2017 Microlearning: Toxicities Series has been developed with content from abstract and faculty presentations conducted at the Society for Immunotherapy of Cancer 32nd Annual Meeting (SITC 2017). The microlearning series provide a quick, easily accessible format for clinicians and researchers to learn about the latest advances in cancer immunotherapy from experts in the field.  


The Toxicities series contains three modules.

 

 

Module 1: Antibody-Mediated Neutralization of Soluble MIC Significantly Enhances Response to CTLA4 Blockade and Reduces Therapy-Induced Colitis

Jennifer Wu, PhD - Northwestern University


Module 2: Pharmacological Management of irAEs

Nathan Dahl, PharmD, R.Ph, BCOP - Clovis Oncology


Module 3: Variance from Evidence-Based Management of Immune-Related Adverse Events Among Healthcare Providers: Analysis of an Online Management Decision Tool

Krista Marcello, BA - Clinical Care Options, LLC

 

 

Target Audience

These modules have been designed to meet the educational needs of researchers and healthcare professionals involved in cancer research and clinical care.

 

Course Available Beginning: August 16, 2018

 

 

Course Objectives
Upon completion of this activity, participants will be able to:
  • Understand how immunotherapies can cause unique toxicities.
  • Recognize symptoms of immune-related adverse events.
  • Describe optimal management of immune-related toxicities.
Register Now
In order to access this program after registering, a SITC account will be provided for you based on the information you have entered.

To access your account after your purchase, use the My Account links on the left hand side of this page to login using the information your provide here.
According to our records there is already a SITC account using the email address you have provided.

To continue with your registration please enter your account password. If you do not know your account password you can retrieve it here: Forgot Password?
First Name:
Last Name:
Email:
Confirm Email:
Which degree best describes you? :
Other area of specialization, please describe::
What is your area of specialization?:
Other primary work setting, please describe: :
Which of the following best describes your primary work setting? :
If more than one professional role applies to you, please enter the additional roles here:
Other professional role, please describe:
What is your professional role? (If more than one applies to you, type additional roles below):
Other degree, please describe:
Product:
SITC 2017 Microlearning: Toxicities Series
The email address you have entered has an existing SITC account.

Please enter your password in the field below. Forgot Password?

Email:
Password:
Country:
Billing Address:
City:
State:
State/Province:
Zip:
Expiration: 
Pre-Test: Module 1

Before beginning the presentation, please complete the brief pre-test questions.

Module 1: Antibody-Mediated Neutralization of Soluble MIC Significantly Enhances Response to CTLA4 Blockade and Reduces Therapy-Induced Colitis

The SITC 2017 Microlearning: Toxicities Series has been developed with content from abstract and faculty presentations conducted at the Society for Immunotherapy of Cancer 32nd Annual Meeting (SITC 2017). This is the first of three modules in the SITC 2017 Microlearning: Toxicities Series.

Speaker Information
Jennifer Wu, PhD  [ view bio ]
Pre-Test: Module 2

Before beginning the presentation, please complete the brief pre-test questions.

Module 2: Pharmacological Management of irAEs

The SITC 2017 Microlearning: Toxicities Series has been developed with content from abstract and faculty presentations conducted at the Society for Immunotherapy of Cancer 32nd Annual Meeting (SITC 2017). This is the second of three modules in the SITC 2017 Microlearning: Toxicities Series.

Speaker Information
Nathan Dahl, PharmD, P. Ph, BCOP  [ view bio ]
Pre-Test: Module 3

Before beginning the presentation, please complete the brief pre-test questions.

Module 3: Variance from Evidence-Based Management of Immune-Related Adverse Events Among Healthcare Providers: Analysis of an Online Management Decision Tool

The SITC 2017 Microlearning: Toxicities Series has been developed with content from abstract and faculty presentations conducted at the Society for Immunotherapy of Cancer 32nd Annual Meeting (SITC 2017). This is the final of three modules in the SITC 2017 Microlearning: Toxicities Series. 

Speaker Information
Krista Marcello, BA  [ view bio ]
Individual topic purchase: Selected